Data Insights

Astodrimer by Starpharma for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval

Astodrimer is under clinical development by Starpharma and currently in Phase I for Coronavirus Disease 2019 (COVID-19). According to GlobalData,...

Data Insights

Docetaxel by Starpharma for Pancreatic Cancer: Likelihood of Approval

Docetaxel is under clinical development by Starpharma and currently in Phase II for Pancreatic Cancer. According to GlobalData, Phase II...

Likelihood of Approval and Phase Transition Success Rate Model - Docetaxel in Pancreatic Cancer

Data Insights

Docetaxel by Starpharma for Bile Duct Cancer (Cholangiocarcinoma): Likelihood of Approval

Docetaxel is under clinical development by Starpharma and currently in Phase II for Bile Duct Cancer (Cholangiocarcinoma). According to GlobalData,...

Likelihood of Approval and Phase Transition Success Rate Model - Docetaxel in Bile Duct Cancer (Cholangiocarcinoma)

Data Insights

Docetaxel by Starpharma for Ocular Melanoma: Likelihood of Approval

Docetaxel is under clinical development by Starpharma and currently in Phase II for Ocular Melanoma. According to GlobalData, Phase II...

Likelihood of Approval and Phase Transition Success Rate Model - Docetaxel in Ocular Melanoma

Data Insights

Docetaxel by Starpharma for Esophageal Cancer: Likelihood of Approval

Docetaxel is under clinical development by Starpharma and currently in Phase II for Esophageal Cancer. According to GlobalData, Phase II...

Likelihood of Approval and Phase Transition Success Rate Model - Docetaxel in Esophageal Cancer

Data Insights

Docetaxel by Starpharma for Solid Tumor: Likelihood of Approval

Docetaxel is under clinical development by Starpharma and currently in Phase II for Solid Tumor. According to GlobalData, Phase II...

Likelihood of Approval and Phase Transition Success Rate Model - Docetaxel in Solid Tumor

Data Insights

Docetaxel by Starpharma for Sarcomas: Likelihood of Approval

Docetaxel is under clinical development by Starpharma and currently in Phase II for Sarcomas. According to GlobalData, Phase II drugs...

Likelihood of Approval and Phase Transition Success Rate Model - Docetaxel in Sarcomas

Data Insights

Docetaxel by Starpharma for Gastric Cancer: Likelihood of Approval

Docetaxel is under clinical development by Starpharma and currently in Phase II for Gastric Cancer. According to GlobalData, Phase II...

Likelihood of Approval and Phase Transition Success Rate Model - Docetaxel in Gastric Cancer

Data Insights

Docetaxel by Starpharma for Non-Small Cell Lung Cancer: Likelihood of Approval

Docetaxel is under clinical development by Starpharma and currently in Phase II for Non-Small Cell Lung Cancer. According to GlobalData,...

Likelihood of Approval and Phase Transition Success Rate Model - Docetaxel in Non-Small Cell Lung Cancer